Semax

Semax is a synthetic nootropic peptide used primarily for cognitive enhancement, focus, memory, and neuroprotection. It increases BDNF (brain-derived neurotrophic factor) and protects neurons from hypoxic damage while improving memory and attention. developed by russian researchers specifically for stroke recovery and cognitive enhancement.

If you're looking for something that sharpens mental performance without the jitteriness, crashes, or dependency that comes with stimulants, this is one of the most well-researched options available. It's been a prescription medication in Russia since the early 1990s, used clinically for stroke recovery, traumatic brain injury, cognitive decline, and optic nerve disorders. It's on Russia's List of Vital & Essential Drugs. Outside of that clinical context, it's gained a large following in the nootropic community for its effects on focus, learning, mood, and mental stamina.

Semax is a seven-amino-acid peptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from a fragment of adrenocorticotropic hormone (ACTH), specifically the ACTH(4-10) segment. The critical distinction is that unlike ACTH itself, Semax does not stimulate cortisol release or trigger any hormonal activity. The researchers who developed it at the Russian Academy of Sciences stripped the hormonal effects and kept the neurotrophic ones, then added a Pro-Gly-Pro extension to the C-terminus to make it resistant to enzymatic breakdown and extend its duration of action from minutes to 20-24 hours.

The primary mechanism is upregulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in the hippocampus and frontal cortex. BDNF is essentially fertilizer for your neurons, it supports the growth, survival, and plasticity of brain cells. One study found Semax increases BDNF levels by approximately 1.4x and doubles the expression of TrkB receptors (the receptors through which BDNF exerts its effects). This translates to improved synaptic plasticity, better memory consolidation, and enhanced learning capacity. Semax also activates serotonergic and dopaminergic brain systems, which is where the mood, motivation, and focus effects come from. A rodent study confirmed it activates both systems without the tolerance or crash pattern you see with traditional stimulants. It also inhibits enkephalinase enzymes, which slows the breakdown of your body's natural pain-modulating and mood-regulating peptides.

There's also evidence Semax interacts with the melanocortin receptor system, specifically acting as an antagonist or partial agonist at MC4 and MC5 receptors. This is still being studied, but melanocortin signalling plays a role in appetite regulation, stress response, inflammation, and sexual function, so it's a potentially meaningful secondary pathway.

Cognitive enhancement: In a study of healthy individuals tested after an 8-hour work shift, a single intranasal dose of Semax produced 71% accuracy on a memory test versus 41% in controls. An fMRI study of 24 healthy subjects found that 1% Semax solution increased activity in the default mode network, the brain region associated with memory, self-referential thought, and information processing. Russian clinical data also shows improved attention and short-term memory in both healthy subjects and patients with cognitive impairment.

Neuroprotection and stroke recovery: This is where the most clinical data exists. In a study of 110 stroke patients, two 10-day courses of Semax at 6,000 mcg/day (with a 20-day break between courses) increased plasma BDNF levels and improved rehabilitation timelines. Animal models of ischemic stroke consistently show Semax reduces infarct size, improves neurological function, and enhances post-injury cognitive performance. The peptide's immunomodulatory effects also appear to play a significant role here, a genome-wide transcriptional analysis found Semax significantly influenced immune cell gene expression and promoted new blood vessel formation during early ischemia stages.

Mood and stress resilience: Semax has demonstrated antidepressant-like and anxiolytic-like effects in animal models, consistent with its activation of serotonergic and dopaminergic systems. It attenuates behavioral effects of chronic stress exposure. For most users without pre-existing anxiety disorders, this translates to improved emotional resilience, steadier mood, and better stress tolerance. However, a 1996 study noted an anxiogenic component in Semax's behavioral effects, meaning it can worsen anxiety in people who already have elevated baseline anxiety. If you run anxious, this peptide may not be ideal for you, or you may want to pair it with something like Selank (its anxiolytic counterpart developed by the same Russian research group).

Immune modulation: Semax enhances the expression of chemokines and immunoglobulins and increases immune cell mobility. This isn't its primary use case, but it's a meaningful secondary benefit, particularly during recovery from illness or injury.

Variants: Semax comes in several forms. Standard Semax is the original with the most clinical data behind it. N-Acetyl Semax adds acetylation at the N-terminus, which protects it from degradation by leucine aminopeptidase, making it last roughly 30 minutes longer in blood plasma and potentially offering more sustained effects. N-Acetyl Semax Amidate adds both acetylation and amidation (protection at both ends), making it the most stable and longest-lasting variant with a reported duration of 6-12 hours versus 2-4 hours for standard Semax. The trade-off is that the acetylated variants have less direct clinical research, most of the Russian clinical data is on standard Semax. If you're going with an acetylated form, dose about 30-40% lower than standard Semax due to improved bioavailability.

Women: There's no evidence that Semax works differently in women versus men in terms of its core cognitive and neuroprotective mechanisms. BDNF upregulation, dopamine and serotonin modulation, and neuroprotection aren't sex-dependent pathways. The same doses and protocols apply. The main sex-specific caution is pregnancy and breastfeeding, where there simply isn't enough safety data, so it should be avoided. Women on hormonal contraception don't need to adjust dosing. One area worth noting is that Semax's modulation of the stress response (via its ACTH-derived structure and melanocortin receptor activity) could theoretically interact with HPA axis dynamics, which do differ between sexes, but there's no clinical evidence of this causing issues in women.

Dosage:

Intranasal (most common and most studied route): 200-600 mcg daily, split into 1-2 doses. The standard Russian pharmaceutical product is a 0.1% solution delivering approximately 50 mcg per drop. Typical cognitive enhancement protocol is 1-2 drops per nostril, twice daily. For clinical neurological use (stroke recovery, optic nerve), the 1% solution is used at 2-3 drops per nostril, 3-4x daily (up to 6,000 mcg/day), but this is a medical context and not relevant for most users

Subcutaneous injection: 300-800 mcg once daily in the morning. SubQ provides more sustained systemic absorption compared to intranasal. Start at the lower end and titrate up based on response

N-Acetyl Semax or N-Acetyl Semax Amidate: Dose 30-40% lower than standard Semax due to improved stability and bioavailability. If you'd normally use 600 mcg of standard Semax, start with 400 mcg of an acetylated variant. These also require less frequent dosing, once daily is usually sufficient versus twice daily for standard

Timing: First dose in the morning. If splitting doses, take the second before 2-3 PM to avoid sleep disruption. Semax enhances dopaminergic tone and alertness, so evening dosing can interfere with sleep

Cycle length: 10-14 days for cognitive enhancement, up to 30 days for more sustained neuroprotective goals. Follow each cycle with a break equal to the cycle length (e.g. 14 days on, 14 days off). Most users repeat cycles every 1-3 months. Continuous long-term daily use is not recommended because Semax works through BDNF and neurotrophic signalling pathways that can downregulate with chronic overstimulation

No fasting requirement. Food does not significantly impact absorption or efficacy

Storage: Lyophilized powder at -20°C. Once reconstituted, refrigerate at 2-8°C and use within 30 days. Avoid freeze-thaw cycles. Intranasal formulations may be stable at room temperature depending on the manufacturer, but refrigeration is safest

No female-specific dose adjustment needed. Same protocols apply across sexes

Here's what you can expect:

Semax is one of the faster-acting nootropic peptides. Many users report noticeable improvements in focus, mental clarity, and verbal fluency within 30-60 minutes of intranasal administration. The acute cognitive effects (sharper thinking, improved concentration, better information processing) are typically apparent from the first dose, though they compound over the course of a cycle as BDNF levels build. By day 3-5 of a cycle, most users report a noticeable uplift in sustained attention, working memory, and overall mental energy. Mood improvements and stress resilience tend to emerge over 1-2 weeks. Neuroprotective benefits (which you won't "feel" subjectively) require longer, consistent use and are really the domain of clinical protocols. After stopping a cycle, many users report that some cognitive benefits persist for days to weeks, likely because the BDNF and NGF upregulation doesn't immediately reverse.

Side effects & risks:

Nasal irritation is the most common side effect with intranasal use, including dryness, mild burning, or discomfort. About 10% of users in Russian clinical data experienced visible discoloration of the nasal mucosa with extended use

Headache, restlessness, or insomnia can occur, particularly if dosed too late in the day or at higher doses. These are generally mild and resolve with dose adjustment or earlier timing

Increased anxiety in anxiety-prone individuals. This is an important one. While Semax has anxiolytic properties for most users, it has a documented anxiogenic component that can worsen symptoms in people with pre-existing anxiety disorders. If you notice increased agitation or nervousness, lower the dose or discontinue

Blood glucose elevation in diabetics: Russian clinical data reported about 7.4% of diabetic patients experienced mild increases in blood glucose during Semax use. If you're diabetic or insulin resistant, monitor glucose closely

Hair thinning (theoretical, not clinically confirmed): Because Semax significantly upregulates BDNF, and elevated BDNF has been linked in some studies to hair cycle disruption in individuals predisposed to baldness, there are anecdotal reports of increased hair shedding. The clinical data doesn't confirm this, but it's worth being aware of, particularly if you're already prone to androgenetic alopecia. If you notice increased shedding during a cycle, consider a shorter cycle length or switching to lower doses

Emotional sensitivity or irritability has been reported by some users, likely related to dopamine and serotonin modulation. Usually resolves with dose reduction

No serious adverse events have been reported in any published clinical or preclinical trial to date. No reports of toxicity, organ damage, or dependence

Contraindications: Known allergy to peptide formulations, uncontrolled hypertension, unstable cardiovascular disease, severe psychiatric disorders (particularly mania or psychosis), pregnancy, and breastfeeding. Avoid combining with MAO inhibitors or other drugs that significantly affect dopamine and serotonin without medical supervision

🩸

Blood markers

Fasting glucose and HbA1c , check at baseline if you have any history of insulin resistance or diabetes, as Semax may cause mild glucose elevation. Recheck at end of cycle if diabetic.

For most healthy users, no specific blood monitoring is required. Semax has a strong safety profile with decades of clinical use. If you're diabetic, track glucose. If you're running it alongside other compounds, include it in your standard panel schedule.

Semax is not FDA-approved and is classified as a research peptide outside of Russia and Eastern Europe.